ImageneBio (IMA) Return on Equity (2020 - 2024)

Historic Return on Equity for ImageneBio (IMA) over the last 5 years, with Q3 2024 value amounting to 0.38%.

  • ImageneBio's Return on Equity rose 200.0% to 0.38% in Q3 2024 from the same period last year, while for Sep 2024 it was 0.38%, marking a year-over-year increase of 200.0%. This contributed to the annual value of 0.43% for FY2023, which is 400.0% down from last year.
  • Latest data reveals that ImageneBio reported Return on Equity of 0.38% as of Q3 2024, which was up 200.0% from 0.45% recorded in Q2 2024.
  • In the past 5 years, ImageneBio's Return on Equity ranged from a high of 0.5% in Q4 2020 and a low of 0.74% during Q1 2021
  • Its 5-year average for Return on Equity is 0.32%, with a median of 0.39% in 2023.
  • As far as peak fluctuations go, ImageneBio's Return on Equity tumbled by -6600bps in 2021, and later surged by 5400bps in 2022.
  • ImageneBio's Return on Equity (Quarter) stood at 0.5% in 2020, then tumbled by -133bps to 0.17% in 2021, then tumbled by -171bps to 0.45% in 2022, then grew by 7bps to 0.42% in 2023, then increased by 9bps to 0.38% in 2024.
  • Its Return on Equity was 0.38% in Q3 2024, compared to 0.45% in Q2 2024 and 0.43% in Q1 2024.